MENU

KLTO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Klotho Neurosciences (KLTO) Ownership - Who owns Klotho Neurosciences?

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

29.93M

P/E Ratio

N/A

Total Cash

7.35M

Projected Growth

N/A

Total Debt

1.77M

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

0.10

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KLTO

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details